Skip to main content
Equibles

HSBC HOLDINGS PLC

Position in PTCT — Ptc Therapeutics, Inc.

CIK 873630 LONDON, X0
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$10,717,400
-$4,752,128 QoQ
Shares Held
131,389
-42.1% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#75
of 383 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

HSBC HOLDINGS PLC holds $1,221,504,678 across 135 Biotechnology names. PTCT ranks #22 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 676,247 $335,912,169
2 REGN
Regeneron Pharmaceuticals, Inc.
 382,028 $238,209,735
3 INCY
Incyte Corp
 1,307,743 $148,245,744
4 RPRX
Royalty Pharma plc
 1,224,925 $68,681,542
5 MRNA
Moderna, Inc.
 636,199 $44,553,014
6 ALNY
Alnylam Pharmaceuticals, Inc.
 115,279 $34,702,435
7 INSM
INSMED Inc
 279,961 $29,849,438
8 BMRN
Biomarin Pharmaceutical Inc
 307,543 $17,597,610

All Filings in PTCT

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $10,717,400 131,389
2026-03-31 $15,469,528 227,059
2025-12-31 $921,242 12,128
2025-09-30 $10,954,482 178,499
2025-06-30 $1,465,688 30,010
2025-03-31 $902,552 17,711
2024-12-31 $743,365 16,468
2024-09-30 $777,875 20,967
2024-06-30 $578,512 18,918
2024-03-31 $674,858 23,199
2023-12-31 $476,402 17,286
2023-09-30 $680,187 30,352
2023-06-30 $1,588,853 39,067
2023-03-31 $669,730 13,826
2022-12-31 $1,739,253 45,566
2022-09-30 $791,051 15,758
2022-06-30 $967,327 24,147
2022-03-31 $2,309,076 61,889
2021-12-31 $2,818,528 70,764
2021-09-30 $2,577,683 69,274
2021-06-30 $1,155,365 27,333
2021-03-31 $853,860 18,033
2020-12-31 $431,482 7,070
2020-09-30 $1,141,915 24,426
2020-03-31 $223,005 4,999